Clinical Trials List
2024-02-27 - 2030-01-27
Phase III
Recruiting1
Suspended15
ICD-10I25.10
Atherosclerotic heart disease of native coronary artery without angina pectoris
ICD-9429.2
Cardiovascular disease, unspecified
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Suspended
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 李威杰 無
- 周銘霆 無
- Zhih-Cherng Chen 無
- 施志遠 無
- 蔣俊彥 無
- 林志憲 無
- Chia-Te Liao 無
The Actual Total Number of Participants Enrolled
0 Suspended
The Actual Total Number of Participants Enrolled
0 Suspended
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- Chun-Yuan Chu Division of Cardiovascular Diseases
- Ye-Hsu Lu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- Po-Chao Hsu Division of Cardiovascular Diseases
- 朱志生 Division of Cardiovascular Diseases
- 卓士傑 Division of Cardiovascular Diseases
- Wei-Chung Tsai Division of Cardiovascular Diseases
- Hsiang Chun Lee Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Suspended
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 吳至行 無
- Shih-Hung Chan 無
- Po-Tseng Lee 無
- Ping-Yen Liu 無
- 張獻元 無
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 陳隆景 無
- Min-Ji Charng 無
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 陳彥舟 無
- Chien-Yi Hsu 無
- 陳志維 無
- 鄭宇倫 無
- Yung-Ta Kao 無
- Tsung-Lin Yang 無
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 江君揚 無
- 林柏志 無
- HUNG-JU LIN 無
- 賀立婷 無
- 蔡承烜 無
The Actual Total Number of Participants Enrolled
0 Suspended
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 劉文浩 無
- 鍾文榮 無
- 方燕楠 無
- Huang-Chung Chen 無
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- Hao-min Cheng 無
- 李慶威 無
- Chern-En Chiang Division of Cardiovascular Diseases
- 黃偉銘 無
- Wen-Chung Yu 無
- 蔡依霖 無
The Actual Total Number of Participants Enrolled
0 Suspended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
300~425 participants
-
Global
15000 participants
